Strand aims to carve out a unique niche in the area of clinical research
Dr Ramesh Hariharan, CEO, Strand Life Sciences, elaborates on his company’s future projects, growth strategies and more, in an…
Author
‘Serialisation can analyse business value’ | Shashikant Joag
Existence of Falsified Medicines over the pharmacy counter thus has remained a grave concern for regulators all over the world
‘It is a major step for anti-counterfeiting’ | Parag Kothari
Marketing Authorisation Holders (MAHs) will be required to upload their products serialisation codes to the European Medicines…
EU FMD: Uniform practice for all
In less than four months, by February 9, 2019 the Falsified Medicines Directive (FMD) will be implemented in more than 30…
DoP urges pharma industry to develop innovative drugs
Pharmexcil organises seminar on Financial Schemes for Pharma industry and Outstanding Export Performance Awards at its 14 th…
Making it future ready
On Teachers’ Day, experts comment on ways to improve pharmacy education in the country
India adopts proactive approach in adopting biosimilars to bring down cost
Introduction of new drugs in the form of biosimilars will bring in new drug delivery system. The Indian pharma companies are…
Cipla declares its fourth quarter results
The R&D investments in the quarter ramped up to ~7.6 per cent of revenues
Cipla Limited announced its audited consolidated…
Annual Innopack Pharma Confex to be held in Mumbai
CPhI Conferences will host the ‘The 3rd edition of The India Packaging Awards’ on 24th May 2018
Glenmark Pharma submits NDA application for Ryaltris
Ryaltris is for seasonal allergic rhinitis and it is formerly known as GSP 301 nasal spray, and it is the company’s leading…